NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) › Operating Cash FlowNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$5.1K2011: -$27.4K2017: -$2.11M2019: -$5.40M2020: -$3.43M2021: -$8.60M2022: -$7.52M2023: -$12.89M2024: -$11.01M2025: -$2.84M-$2.84M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$2.84M+74.2%2024-$11.01M+14.5%2023-$12.89M-71.4%2022-$7.52M+12.6%2021-$8.60M-151.2%2020-$3.43M+36.5%2019-$5.40M—2017-$2.11M—2011-$27.4K-438.6%2010-$5.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share